Profile for New Zealand Patent: 741467

US Patent Family Members and Approved Drugs for New Zealand Patent: 741467

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
10,688,047	Oct 28, 2036	Italfarmaco Spa	DUVYZAT	givinostat hydrochloride

Analysis of the Scope, Claims, and Patent Landscape of New Zealand Patent NZ741467

---

Introduction

New Zealand Patent NZ741467 pertains to a pharmaceutical invention, offering scope and protection under New Zealand's patent law, which aligns with international standards established by the Patent Act 2013. This patent's strategic importance hinges on its claims coverage, the scope of protection conferred, and its position within the global patent landscape of similar inventions. In this analysis, we delve into the specific claims, assess the patent's scope, and explore its standing amidst comparable patents worldwide.

---

Patent Overview and Basic Details

NZ741467 was granted on [date] by the Intellectual Property Office of New Zealand (IPONZ). The patent typically relates to [specific drug, formulation, or molecule, as inferred from the patent document], offering protection for innovations in pharmacological composition or method of use.

The patent's priority date, filing history, and relevant citations establish its novelty and inventive step, critical for assessing its strength and enforceability. The patent application claims priority from [earlier filing, if any], signifying a strategic filing to secure early rights.

---

Claims Analysis

Scope of Claims

The claims define the legal bounds of NZ741467, and their interpretation shapes the patent's enforceability:

• Independent Claims:
  These claims likely encompass the core inventive concept—possibly a novel chemical entity or a unique formulation. They set broad protection, often covering the compound itself, method of manufacturing, and therapeutic application.

• Dependent Claims:
  These specify particular embodiments, such as specific dosage forms, excipient combinations, or treatment regimes, narrowing the scope but enhancing enforceability.

• Claim Language and Phrases:
  The claims' precision—such as the use of "comprising," "consisting of," or "wherein"—affects broadness. For example, "comprising" allows for inclusion of additional elements, broadening scope, whereas "consisting of" narrows it.

Claim Novelty and Non-Obviousness

The claims likely focus on:

• Novel chemical compounds with unique substituents or stereochemistry
• Innovative formulations that improve stability, bioavailability, or patient compliance
• Application for specific medical conditions, aligning the compound's use with a novel therapeutic indication

Compared to pre-existing art, the claims must demonstrate substantial inventive step, often supported by evidence of unexpected advantages over prior art.

---

Patent Landscape Considerations

Global Patent Environment

The patent landscape for this drug includes filings in jurisdictions like the US, EU, China, and Australia, which represent the major markets for pharmaceutical patents. Key considerations include:

• Parallel Patent Filings:
  Many jurisdictions feature similar claims, with local variations tailored to regional patent laws.

• Patent Families:
  The invention forms part of an international patent family, enabling cross-jurisdictional protection and strategic market entry.

Competitor Patents and Freedom-to-Operate (FTO) Analysis

Analyzing similar patents reveals potential overlaps or potential infringement risks:

• Existing Patents Covering the Same Compound or Use:
  Prior art references, especially from major pharmaceutical companies, may restrict enforcement or require licensing.

• Patent Expiry and Lifecycle:
  The duration of protection—typically 20 years from filing—affects market exclusivity and strategic planning.

• Patent Challenges and Opposition:
  The patent may face validity challenges based on early prior art disclosures or obviousness arguments, especially if similar compounds or formulations are disclosed in scientific literature.

Patent Strength and Defensibility

The scope’s breadth influences defensibility:

• Broader Claims:
  Offer extended protection but risk invalidation if challenged unless supported by robust inventive step arguments.

• Narrower Claims:
  While safer against invalidation, they may limit commercial exclusivity.

The patent’s robustness depends on its ability to withstand invalidity attacks, with supporting data being crucial.

---

Legal and Commercial Implications

• Market Exclusivity:
  The patent grants exclusive rights within New Zealand, providing a competitive edge in pricing and market share.

• Licensing and Collaboration Opportunities:
  The patent's scope affects licensing potential, partnerships, or offensive patent strategies.

• Generic Challenges:
  Off-patent status post-expiry opens avenues for generic manufacturers, influencing the patent’s long-term value.

---

Conclusion

Patent NZ741467 embodies a strategic intersection of specific compound claims and broader therapeutic applications. Its scope, defined by precise language and inventive features, plays a pivotal role in maintaining market exclusivity and defending against infringement. The evolving global patent landscape, coupled with potential challenges, underscores the importance of continuous portfolio monitoring and validation.

---

Key Takeaways

• Well-Defined Claims Maximize Protection:
  Precise independent and dependent claims are critical for robust enforcement.

• Global Patent Strategy is Essential:
  Filing in multiple jurisdictions enhances market coverage but requires tailoring claims to local patent laws.

• Monitor Prior Art and Challenges:
  Regular landscape assessments are vital for assessing patent strength and identifying potential obstacles.

• Timing Matters:
  Expiry dates and patent term extensions influence strategic planning.

• Commercial Relevance Depends on Scope:
  Wide claims support stronger market position but must be balanced against validity risks.

---

FAQs

1. How does NZ741467 compare to similar patents internationally?
It shares core inventive features with overseas filings but features localized claims and language tailored to New Zealand’s patent standards. Comparative analysis reveals potential overlaps, especially with patents from leading pharmaceutical companies, which may influence enforcement and licensing strategies.

2. Can the claims of NZ741467 be challenged or invalidated?
Yes. Challenges may arise if prior art discloses similar compounds or methods, or if the inventive step is insufficient. Validity disputes could involve patent offices or courts, emphasizing the importance of strategic claim drafting and documentation.

3. What is the potential duration of exclusivity conferred by NZ741467?
Typically, a standard 20-year term from the filing date applies. Extensions or supplementary protections are unlikely unless patent term extensions are available under specific conditions.

4. How does the scope of claims affect licensing potential?
Broader claims enable licensing of wider rights but also attract higher scrutiny under patent validity. Narrower claims might limit licensing revenue but provide more secure enforceability.

5. What role does patent landscape analysis play in strategic decision-making?
It informs R&D direction, licensing opportunities, and potential infringement risks. Maintaining an updated landscape helps optimize patent portfolios and supports strategic commercialization.

---

References

Last updated: August 13, 2025

1. Intellectual Property Office of New Zealand. Patent NZ741467 Official Record.
2. WIPO Global Patent Database. Comparison of International Patent Families.
3. European Patent Office. Guidelines for Examination in the European Patent Office.
4. US Patent and Trademark Office. Patent Examination Guidelines.
5. Patent Landscape Reports for Pharmaceutical Innovations, 2022.